Trius Announces Publication of Tedizolid ESTABLISH 1 Trial in JAMA

[at noodls] – SAN DIEGO, Feb. 12, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery and development of innovative antibiotics for serious infections, … more

View todays social media effects on TSRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Trius is hiring next, click here to view